Variant report
Variant | esv3365269 |
---|---|
Chromosome Location | chr17:19542710-19544708 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLC47A2-2 | chr17:19543740-19543863 | XLOC_012417 |
2 | lnc-SLC47A2-2 | chr17:19542441-19543431 | XLOC_012417 |
No data |
No data |
Variant related genes | Relation type |
---|---|
BCL2L11 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182577046 | chr17:19542745-19542746 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs528791123 | chr17:19542750-19542751 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs542008293 | chr17:19542804-19542805 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs374163675 | chr17:19542807-19542808 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs561994012 | chr17:19542813-19542814 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs530864205 | chr17:19542872-19542873 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs551065087 | chr17:19542880-19542881 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs139464310 | chr17:19543037-19543038 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs113265104 | chr17:19543111-19543112 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs533384903 | chr17:19543121-19543122 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs372558667 | chr17:19543152-19543153 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs11871420 | chr17:19543162-19543163 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs566758678 | chr17:19543189-19543190 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs187141802 | chr17:19543190-19543191 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs372370293 | chr17:19543192-19543193 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs569041932 | chr17:19543194-19543195 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs537508301 | chr17:19543195-19543196 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs557856159 | chr17:19543202-19543203 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs78342773 | chr17:19543228-19543229 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs28495827 | chr17:19543254-19543255 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs546438353 | chr17:19543269-19543270 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs140608936 | chr17:19543286-19543287 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs111710980 | chr17:19543290-19543291 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs573196267 | chr17:19543332-19543333 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs12940877 | chr17:19543397-19543398 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs201766101 | chr17:19543434-19543435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575812777 | chr17:19543435-19543436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544351013 | chr17:19543436-19543437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564582973 | chr17:19543437-19543438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371218340 | chr17:19543505-19543506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539280529 | chr17:19543614-19543615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533300054 | chr17:19543648-19543649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558207072 | chr17:19543712-19543713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200067672 | chr17:19543722-19543723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191580879 | chr17:19543773-19543774 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs377389507 | chr17:19543785-19543786 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs535352563 | chr17:19543805-19543806 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs183773764 | chr17:19543816-19543817 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs188105727 | chr17:19543867-19543868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144469971 | chr17:19543943-19543944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549313564 | chr17:19543980-19543981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73981572 | chr17:19544009-19544010 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs538019713 | chr17:19544032-19544033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112429231 | chr17:19544040-19544041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571308586 | chr17:19544075-19544076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs193265706 | chr17:19544104-19544105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9889632 | chr17:19544138-19544139 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs573311536 | chr17:19544146-19544147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185388976 | chr17:19544149-19544150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113143256 | chr17:19544172-19544173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 22543975 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:19534400-19545400 | Weak transcription | A549 | lung |
2 | chr17:19536000-19545600 | Weak transcription | HepG2 | liver |
3 | chr17:19538000-19549400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr17:19538800-19544400 | Weak transcription | Liver | Liver |
5 | chr17:19544400-19544800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr17:19544400-19544800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr17:19544400-19545200 | Enhancers | Liver | Liver |
8 | chr17:19544400-19546400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr17:19544400-19547000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr17:19544600-19545800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr17:19544600-19546000 | Enhancers | HMEC | breast |